Filing Flows › Seres Therapeutics (MCRB) › How it makes money
How Seres Therapeutics (MCRB) makes money
Seres Therapeutics (MCRB) made $593K of revenue in the third quarter 2026 (Q3 2026), +69% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $593K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $593K | +69% |
| Q2 2026 | $736K | — |
| Q1 2026 | $358K | — |
| Q4 2025 | $438K | — |
| Q3 2025 | $351K | — |
From Seres Therapeutics' 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Seres Therapeutics make money?
Seres Therapeutics (MCRB) made $593K of revenue in the third quarter 2026 (Q3 2026), +69% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.